Bleeding and Thrombosis Outcomes in Older Patients With Myelodysplastic Syndromes – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about the recent article by Mansour Gergi et al, adding:
“Impact of Thrombosis and Bleeding on Survival of older People with Myelodysplastic Syndromes (MDS): A Population Analysis
A large population study of nearly 14,000 older MDS patients revealed that bleeding complications significantly increase mortality risk, while VTE’s impact may involve unmeasured confounding factors.”
Title: Impact of Thrombosis and Bleeding on Survival of older People with Myelodysplastic Syndromes (MDS): A Population Analysis
Authors: Mansour Gergi, Andrew Sparks, Neil A Zakai, Diego Adrianzen Herrera
Read the Full Article on JTH
More posts about Journal of Thrombosis and Haemostasis on Hemostasis Today.
-
Aug 10, 2026, 06:06Mostafa Faisal: What Does High Ferritin Really Mean
-
Aug 10, 2026, 05:45Colin Holburn: Key Laboratory Clues to End Organ Damage
-
Aug 10, 2026, 05:35George Dimitrov: SII and Cancer – What Can This Marker Really Tell Us
-
Aug 10, 2026, 05:01Emicizumab and Breastfeeding New Clinical Evidence – JTH
-
Aug 10, 2026, 04:53Abdulaziz Elnusiry: Pulmonary Embolism – The Silent Emergency We Need to Talk About
-
Aug 10, 2026, 04:33Saba Javed: Managing VTE in Cancer Patients With Thrombocytopenia
-
Aug 10, 2026, 04:21Heghine Khachatryan: When Cancer Is Not Enough to Predict VTE Risk
-
Aug 10, 2026, 04:09Ney Carter Borges: How Polyphenols Influence Endothelial Function
-
Aug 10, 2026, 03:54Maria Cherska: One Pill, Better Adherence, Same LDL-C Control